![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | |||
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 2016 | Founding Date 1990 |
Type | Type Private | Type Private | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations San Francisco, US HQ Bozeman, US | Locations Arrasate, ES HQ | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations Ewing Township, US HQ |
Employees | Employees 2216% increase | Employees 26 | Employees 156% decrease | Employees 4 |
Funding | ||||
Total funding raised | Total funding raised $ 17.8m | Total funding raised N/A | Total funding raised $ 17m | Total funding raised N/A |
Microliquid is a healthcare company that provides IVD and cell therapy solutions.
View company
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View companyCellOxess is a company that provides healthcare and biotechnology services.
View company